Condition (MeSH)
Pneumonia, Pneumococcal
ClinicalTrials.gov lists 44 trials for Pneumonia, Pneumococcal or a narrower condition beneath it. Merck Sharp & Dohme LLC has the most among industry and government lead sponsors, with 4.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
44 of the 44 trials are tagged with Pneumonia, Pneumococcal itself; the rest are tagged with a narrower condition beneath it.
When did Pneumonia, Pneumococcal trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 3 |
| 2023 | 1 |
| 2022 | 5 |
| 2021 | 3 |
| 2020 | 3 |
| 2019 | 5 |
| 2018 | 5 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pneumonia, Pneumococcal trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 8 |
| Phase 1/2 | 2 |
| Phase 2 | 3 |
| Phase 3 | 8 |
| Phase 4 | 11 |
| Not applicable | 6 |
| Observational | 6 |
How many Pneumonia, Pneumococcal trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 34 |
| Terminated | 2 |
| Withdrawn | 1 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pneumonia, Pneumococcal trials? (8)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 3 |
| China National Biotec Group Company Limited | 3 |
| Pfizer | 3 |
| Sanofi | 2 |
Showing 5 of 8 sponsors.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Synflorix | 3 |
| PNEUMOVAX | 3 |
| V116 | 3 |
| Pneumococcal Vaccine | 2 |
| Pneumococcal Vaccine Formulation 3 | 2 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pneumonia, Pneumococcal trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pneumonia | 45 | 7 |
| Angina pectoris | 42 | 1 |
| Basal cell carcinoma | 39 | 2 |
| Gastroenteritis | 36 | 4 |
| Atrial fibrillation | 29 | 3 |
Showing 5 of 10 adverse events.
Which publications cover Pneumonia, Pneumococcal? (119)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Multicentre case-control study of pneumococcal infections among children with pneumonia in Peninsular Malaysia (MY-Pneumo): a study protocol. | BMC public health | 2024 | Yes |
| Platelet p110β mediates platelet-leukocyte interaction and curtails bacterial dissemination in pneumococcal pneumonia. | Cell reports | 2022 | Yes |
| A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany. | The European respiratory journal | 2022 | Yes |
| Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia: a systematic review and meta-analysis. | BMJ open | 2022 | Yes |
| Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia. | EBioMedicine | 2021 | Yes |
Showing 5 of 119 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.